Cardiovascular Sciences nets $1M in financing
Cardiovascular Sciences, a technology company focused on the development of medical products, has secured a capital investment of $1 million from Seven Palm Investments.
Larry Hooper, CEO of Cardiovascular Sciences, said the Illinois-based Seven Palm may invest even more in the company.
The investment will allow the Orlando-based company to develop its products more rapidly and enter the marketplace within the next two years, Hooper said.
Cardiovascular Sciences, a client of the University of Central Florida’s (UCF) Technology Incubator, has partnered with the UCF’s department of chemistry on technology to prevent adhesions during surgery.
Larry Hooper, CEO of Cardiovascular Sciences, said the Illinois-based Seven Palm may invest even more in the company.
The investment will allow the Orlando-based company to develop its products more rapidly and enter the marketplace within the next two years, Hooper said.
Cardiovascular Sciences, a client of the University of Central Florida’s (UCF) Technology Incubator, has partnered with the UCF’s department of chemistry on technology to prevent adhesions during surgery.